Boston Elite
Michael Cohen is a co-practice group leader at Brown Rudnick LLP’s Global Life Sciences Group. Cohen advises early stage and mid-market companies in the life sciences and technology industries on various matters, including financing transactions, strategic alliances, and joint ventures. Cohen is well-versed in handling securities law compliance, technology licensing, financing transactions and corporate governance for his clients including private equity funds, portfolio companies and corporate venture groups.
Legal 500 Editorial commentary
Accolades
Boston Elite
Profile
Work Department
Life Sciences Group, Emerging Growth Companies and Venture Capital Group
Position
Partner
Career
Michael Cohen is co-practice group leader of Brown Rudnick’s Global Life Sciences Group and of the firm’s Emerging Growth Companies & Venture Capital Group. He advises on high-profile matters in the life sciences and technology sectors. Michael's clients regularly rely on him to be a true outside general counsel, ready and able to handle matters big and small as they arise.
Michael represents early stage and mid-market companies in corporate structuring, mergers and acquisitions, joint ventures and strategic alliances, financing transactions, and other general transactional matters at all stages of the corporate life cycle. Michael also advises venture, hedge, and private equity funds, universities, corporate venture groups, and portfolio companies in connection with financing transaction deal terms and stockholders' agreements, technology licensing, corporate governance and securities law compliance in connection with private offerings.
Michael also works closely with Brown Rudnick’s London office in counseling U.K. and European clients engaging in transactions involving U.S. concerns.
Content supplied by Brown Rudnick LLP